Ferring Pharmaceuticals is a research-driven biopharmaceutical company dedicated to researching, developing and marketing innovative treatments in a number of key therapeutic areas including reproductive health, urology, and gastroenterology. Ferring has operating subsidiaries in more than 50 countries and markets its products in over 100 countries. Ferring has R&D presence in 8 countries: Brazil, China, Denmark, India, Israel, Japan, Switzerland, and  in the US. The main pharmaceutical development hub is in Copenhagen. The Copenhagen and Parsippany sites drive and execute product innovation and development of new molecular entities as well as further development of our existing in-line products to better meet patient needs or address new disease areas. At its eight R&D centres, Ferring scientists strive to improve existing therapies and to create inventive new treatments that address unmet medical needs and help people of all ages live better. And, in every aspect of our business, we follow the Ferring Philosophy: “People Come First at Ferring”. It’s more than just five simple words. To us, it is a guiding principle that inspires everything we do - from our business practices to our relationships with patients and physicians.

Photo of Ferring Headquarters, Saint-Prex, Switzerland (www.ferring.com)